DK162130C - GRF ANALOG PEPTIDES, METHOD FOR PREPARATION THEREOF, GRF ANALOG PEPTIDES AS THERAPEUTICS, USE OF GRF ANALOG PEPTIDES, METHOD FOR MANUFACTURE OF PHARMACEUTICAL PREPARATIONS CONTAINING GRF peptide analogues and intravenous PHARMACEUTICAL PREPARATIONS CONTAINING GRF ANALOG PEPTIDES - Google Patents
GRF ANALOG PEPTIDES, METHOD FOR PREPARATION THEREOF, GRF ANALOG PEPTIDES AS THERAPEUTICS, USE OF GRF ANALOG PEPTIDES, METHOD FOR MANUFACTURE OF PHARMACEUTICAL PREPARATIONS CONTAINING GRF peptide analogues and intravenous PHARMACEUTICAL PREPARATIONS CONTAINING GRF ANALOG PEPTIDESInfo
- Publication number
- DK162130C DK162130C DK151884A DK151884A DK162130C DK 162130 C DK162130 C DK 162130C DK 151884 A DK151884 A DK 151884A DK 151884 A DK151884 A DK 151884A DK 162130 C DK162130 C DK 162130C
- Authority
- DK
- Denmark
- Prior art keywords
- grf
- analog peptides
- grf analog
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 8
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 4
- 101710142969 Somatoliberin Proteins 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 2
- 239000003814 drug Substances 0.000 title 1
- 238000001990 intravenous administration Methods 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 101000825742 Homo sapiens Somatoliberin Proteins 0.000 abstract 2
- 102100022831 Somatoliberin Human genes 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 150000001408 amides Chemical class 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 1
- 239000007791 liquid phase Substances 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- 238000010532 solid phase synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1. Claims for the Contracting States : BE CH DE FR GB IT LI LU NL SE Polypeptides of the general formula (Leu**27 )-GRF wherein GRF represents at least the first 28 amino acids of the full sequence of natural human growth hormone releasing factor and wherein the carboxyl terminus of the molecule is present in free form or as the amide. 1. Claims for the Contracting State : AT A method for the preparation of polypeptides of the general formula (Leu**27 )-GRF wherein GRF represents at least the first 28 amino acids of the full sequence of natural human growth hormone releasing factor and wherein the carboxyl terminus of the molecule is present in free form or as the amide, characterized in that (a) the protecting groups of a protected polypeptide of corresponding amino acid sequence, which has been synthetized according to the liquid phase method, are cleaved off in a manner known per se, or (b) a carrier resin-bound protected polypeptide of corresponding amino acid sequence, which has been synthetized according to the solid phase method, is treated with anhydrous liquid HF.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47270083A | 1983-03-07 | 1983-03-07 | |
| US47270083 | 1983-03-07 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK151884D0 DK151884D0 (en) | 1984-03-05 |
| DK151884A DK151884A (en) | 1984-09-08 |
| DK162130B DK162130B (en) | 1991-09-23 |
| DK162130C true DK162130C (en) | 1992-03-02 |
Family
ID=23876594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK151884A DK162130C (en) | 1983-03-07 | 1984-03-05 | GRF ANALOG PEPTIDES, METHOD FOR PREPARATION THEREOF, GRF ANALOG PEPTIDES AS THERAPEUTICS, USE OF GRF ANALOG PEPTIDES, METHOD FOR MANUFACTURE OF PHARMACEUTICAL PREPARATIONS CONTAINING GRF peptide analogues and intravenous PHARMACEUTICAL PREPARATIONS CONTAINING GRF ANALOG PEPTIDES |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0121764B1 (en) |
| JP (1) | JPH0786120B2 (en) |
| AT (1) | ATE53220T1 (en) |
| AU (1) | AU574064B2 (en) |
| CA (1) | CA1254000A (en) |
| DE (1) | DE3482387D1 (en) |
| DK (1) | DK162130C (en) |
| IE (1) | IE57097B1 (en) |
| IL (1) | IL71150A (en) |
| NZ (1) | NZ207378A (en) |
| ZA (1) | ZA841638B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4518586A (en) * | 1983-01-13 | 1985-05-21 | The Salk Institute For Biological Studies | GRF Analogs III |
| IL70530A (en) * | 1983-01-13 | 1986-09-30 | Salk Inst For Biological Studi | Synthetic peptides having growth hormone releasing factor activity and compositions containing them |
| BG49718A3 (en) * | 1983-07-15 | 1992-01-15 | Bio- Technology General Corp | Method for preparing of polypeptid with superoxiddismutasne activitty |
| DE3327007A1 (en) * | 1983-07-27 | 1985-02-07 | Hoechst Ag, 6230 Frankfurt | PRODUCTION OF POLYPEPTIDES WITH AN ACID-CARBOXYTERMINUS |
| AU575843B2 (en) * | 1983-08-10 | 1988-08-11 | The Administrators Of The Tulane Eductional Fund | Growth hormone releasing peptides |
| US4617149A (en) * | 1983-09-21 | 1986-10-14 | Eli Lilly And Company | Growth hormone release factor analogs |
| CA1340265C (en) * | 1985-01-18 | 1998-12-15 | Kirston E. Koths | Oxidation resistant muteins |
| US4734399A (en) * | 1985-08-06 | 1988-03-29 | Hoffmann-La Roche Inc. | Growth hormone releasing factor analogs |
| DK382886A (en) * | 1985-08-12 | 1987-02-13 | Syntex Inc | PROCEDURE FOR THE PRODUCTION OF HORMONFACTOR DERIVATIVES |
| EP0448513A3 (en) * | 1990-03-21 | 1991-12-27 | Japat Ltd | Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof |
| JPH06500311A (en) * | 1990-06-29 | 1994-01-13 | エフ・ホフマン―ラ ロシュ アーゲー | Histidine-substituted human growth hormone-releasing factor analog |
| ATE119916T1 (en) * | 1990-12-10 | 1995-04-15 | Hoffmann La Roche | METHOD FOR THE ENZYMATIC PRODUCTION OF GRF(1-44)NH2. |
| WO1992018531A1 (en) * | 1991-04-09 | 1992-10-29 | F. Hoffmann-La Roche Ag | Growth hormone releasing factor analogs |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL70530A (en) * | 1983-01-13 | 1986-09-30 | Salk Inst For Biological Studi | Synthetic peptides having growth hormone releasing factor activity and compositions containing them |
| US4617149A (en) * | 1983-09-21 | 1986-10-14 | Eli Lilly And Company | Growth hormone release factor analogs |
-
1984
- 1984-03-05 IL IL71150A patent/IL71150A/en not_active IP Right Cessation
- 1984-03-05 ZA ZA841638A patent/ZA841638B/en unknown
- 1984-03-05 AT AT84102383T patent/ATE53220T1/en not_active IP Right Cessation
- 1984-03-05 NZ NZ207378A patent/NZ207378A/en unknown
- 1984-03-05 CA CA000448864A patent/CA1254000A/en not_active Expired
- 1984-03-05 AU AU25268/84A patent/AU574064B2/en not_active Ceased
- 1984-03-05 DE DE8484102383T patent/DE3482387D1/en not_active Expired - Fee Related
- 1984-03-05 DK DK151884A patent/DK162130C/en not_active IP Right Cessation
- 1984-03-05 EP EP84102383A patent/EP0121764B1/en not_active Expired - Lifetime
- 1984-03-06 IE IE537/84A patent/IE57097B1/en not_active IP Right Cessation
- 1984-03-06 JP JP59041481A patent/JPH0786120B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59176238A (en) | 1984-10-05 |
| AU2526884A (en) | 1984-09-13 |
| DK151884A (en) | 1984-09-08 |
| ATE53220T1 (en) | 1990-06-15 |
| JPH0786120B2 (en) | 1995-09-20 |
| DE3482387D1 (en) | 1990-07-05 |
| EP0121764B1 (en) | 1990-05-30 |
| DK162130B (en) | 1991-09-23 |
| EP0121764A2 (en) | 1984-10-17 |
| IL71150A0 (en) | 1984-06-29 |
| DK151884D0 (en) | 1984-03-05 |
| ZA841638B (en) | 1984-10-31 |
| NZ207378A (en) | 1989-05-29 |
| AU574064B2 (en) | 1988-06-30 |
| IE57097B1 (en) | 1992-04-22 |
| EP0121764A3 (en) | 1985-12-04 |
| IL71150A (en) | 1987-02-27 |
| IE840537L (en) | 1984-09-07 |
| CA1254000A (en) | 1989-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK162130C (en) | GRF ANALOG PEPTIDES, METHOD FOR PREPARATION THEREOF, GRF ANALOG PEPTIDES AS THERAPEUTICS, USE OF GRF ANALOG PEPTIDES, METHOD FOR MANUFACTURE OF PHARMACEUTICAL PREPARATIONS CONTAINING GRF peptide analogues and intravenous PHARMACEUTICAL PREPARATIONS CONTAINING GRF ANALOG PEPTIDES | |
| DE68928810D1 (en) | Analogs from human insulin | |
| ES8801674A1 (en) | Novel procoagulant proteins. | |
| DE3852636D1 (en) | PEPTIDE ANALOGS FROM INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) OR FACTOR 2 (IGF-2). | |
| IL85020A0 (en) | Pancreatic secretory trypsin inhibitor and variants thereof,process expression vector and recombinant host therefor and pharmaceutical compositions containing it | |
| DE69525544D1 (en) | PEPTIDE ANALOGS OF HUMAN, BASIC MYELINE PROTEIN WITH SUBSTITUTION IN POSITION 91 FOR TREATING MULTIPLE Sclerosis | |
| DE69029377D1 (en) | SUBSTITUTION ANALOGS OF MAGAIN PEPTIDES | |
| ES2015366A6 (en) | Elastase inhibiting polypeptides and process for their preparation by genetic recombination. | |
| KR890010202A (en) | Vectors and Compounds for Expression of the Simogen Form of Human Protein C | |
| DE3751398D1 (en) | Substrate peptides. | |
| DE3650035D1 (en) | THF compositions. | |
| GB1002041A (en) | New polypeptides and process for their manufacture | |
| ATE46173T1 (en) | PHARMACOLOGICALLY ACTIVE PEPTIDES. | |
| ATE91286T1 (en) | VESSEL ACTIVE PEPTIDES. | |
| LI et al. | Distinct behavior of β‐endorphin and corticotropin toward leucine aminopeptidase action | |
| ATE106944T1 (en) | RECOMBINANT POLYPEPTIDES OF HEMORRHAGIC FISH SEPSIS VIRUS. | |
| CA1267086C (en) | Method of administering diuretic atrial peptides | |
| DE59008515D1 (en) | New CNS active hexapeptides with anti-amnestic effects. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed | ||
| PBP | Patent lapsed |